Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.81 |
| ▸ | MAPT | P10636 | 6/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.80 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | DRD4 | P21917 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13165037 | 0.85 | ALDH1A1 (0.72) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL20275888 | 0.82 | MEN1 (0.73) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL13165047 | 0.81 | MAPT (0.76) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL20399311 | 0.76 | HSD17B10 (0.70) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL2368890 | 0.76 | HSD17B10 (0.70) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL13640914 | 0.76 | LMNA (1.00) | ALDH1A1MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL23630827 | 0.75 | HSD17B10 (1.00) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL24455174 | 0.73 | LMNA (0.68) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 | |
| SCHEMBL13164906 | 0.73 | ALDH1A1 (0.80) | ALDH1A1MAPTSMN1; SMN2KDM4ETSHR | |
| SCHEMBL22164391 | 0.72 | HSD17B10 (0.57) | ALDH1A1MAPTSMN1; SMN2KDM4ERXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015136557-A9 | CANCER STEM CELL TARGETING COMPOUNDS | GODAVARI BIOREFINERIES LIMITED (IN) | 2022-05-27 | — | — | WO | disclosed |
| WO-2015136557-A9 | CANCER STEM CELL TARGETING COMPOUNDS | GODAVARI BIOREFINERIES LIMITED (IN) | 2022-05-27 | — | — | WO | disclosed |
| US-20180169100-A1 | Cancer Stem Cell Targeting Compounds | GODAVARI BIOREFINERIES LIMITED (IN) | 2018-06-21 | — | — | US | disclosed |
| US-20180169100-A1 | Cancer Stem Cell Targeting Compounds | GODAVARI BIOREFINERIES LIMITED (IN) | 2018-06-21 | — | — | US | disclosed |
| US-20180169100-A1 | Cancer Stem Cell Targeting Compounds | GODAVARI BIOREFINERIES LIMITED (IN) | 2018-06-21 | — | — | US | disclosed |
| EP-3116867-A2 | CANCER STEM CELL TARGETING COMPOUNDS | Godavari Biorefineries Ltd. (IN) | 2017-01-18 | — | — | EP | disclosed |
| WO-2015136557-A2 | CANCER STEM CELL TARGETING COMPOUNDS | GODAVARI BIOREFINERIES LIMITED (IN) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015136557-A2 | CANCER STEM CELL TARGETING COMPOUNDS | GODAVARI BIOREFINERIES LIMITED (IN) | 2015-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180169100-A1 | Cancer Stem Cell Targeting Compounds | MCL1, MKI67, BAX | ALDH1A1 40/4885MAPT 4707/4885SMN1; SMN2 3201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.